Pharmaceutical Sciences and Innovations in Pharma Industry

Dr. Alkhateeb is the Director of Assessment & Accreditation and Associate Professor of Pharmacy at Texas A&M Health Science Center Irma Lerma Rangel College of Pharmacy. Dr. Alkhateeb has been fortunate to hold a variety of leadership positions throughout his career, including serving as the Founder and Director of the Executive MBA with a concentration in Pharmaceutical & Healthcare Management at University of Charleston, West Virginia. Moreover, he has been selected as a Fellow for the Commission on Accreditation of Health Care Management Education (CAHME). Further, he has published more than 50 peer reviewed articles and over 44 presentations and proceedings related to pharmaceutical care, pharmaceutical marketing, and accreditation and assessment in pharmacy and higher education. Dr. Alkhateeb has served as a field reviewer and evaluator for the following accreditation councils: HLC-NCA, CCAPP, ACPE, ACPE- CPE, and CAHME. Moreover, Dr. Alkhateeb is a member of the 14th Annual Texas A&M Assessment Conference Planning Committee (College Station, TX). Besides being a pharmacist, Dr. Alkhateeb has an MBA degree with concentration in Pharmaceutical Marketing & Management from Aspen University and a PhD in Pharmacy Administration with a concentration in Pharmaceutical Socioeconomics from University of Iowa College of Pharmacy, Iowa.

Dr. Alkhateeb research interests focus on Pharmacy Education and Practice, and Pharmaceutical Marketing. Dr. Alkhateeb has been increasingly drawn to pharmaceutical education research and he is currently investigating the development, delivery and assessment of effective educational programs in schools of Pharmacy. Further, he has published more than 40 peer reviewed articles related to his research interests.

Professor of Pharmacy Practice and Director, Center for Advancement of Drug Research and Evaluation, College of Pharmacy, Western University of Health Sciences, Pomona, USA. Professor Moses SS Chow was awarded his Doctor of Pharmacy in 1972 from the University of California, San Francisco, USA; and he completed his residency in Clinical Pharmacy at VA Hospital, Palo Alto, USA.Currently, Professor Chow is Professor of Pharmacy Practice and Director of the Center for Advancement of Drug Research and Evaluation (CADRE), College of Pharmacy at the Western University of Health Sciences, Pomona, USA. He is also an adjunct professor at the Chinese University of Hong Kong, China.

Dr. Chow has over 30 years of experience in transitional research and clinical studies in the areas of cardiovascular pharmacotherapy and application of pharmacokinetics/pharmacogenomics. His recent research work has been devoted to the development of conventional drugs and herbal medicines (Chinese medicines). He has also established a strong net work with Asian countries, especially China where he served as Director of the Pharmacy School in Hong Kong for 8 years. As Director of the newly established Center for Drug Research and Evaluation at Western U, the focus of his research will be the development of niche pharmaceutical products via formulation optimization as well as new therapeutic approaches. This will be accomplished via collaborative efforts among members in formulation science, bio-analysis/ pharmacokinetics, pharmacology/pharmacogenetics and clinical/outcome studies.

Dr. Hechmi TOUMI graduated from the University Blaise Pascal, Researcher assistant at Wisconsin University and awarded professor at the University of Wales, UK. He is currently a professor of Muscular Skeletal Pathology, the Dean of the Faculty of Science and Technology at the Orleans University France, Vice Director Laboratory EA 4708 - I3MTO and Vice President of the Institute of Research, Treatment & Prevention of Osteoporosis. Hechmi Toumi founded Demasq, Cardiff UK Limited in February 2008 and also serves as its Chief Scientific Officer. He is the inventor of the international patent filing on the use of algorithmic analyses to identify and quantify ‘invisible’ detail in soft tissues in standard radiographs. Professor Toumi is a Member of the Editorial boards the journal Medicine & Science in Sports & Exercise and Journal of Foot and Ankle. His research focuses on Bone, Cartilage and soft tissue injuries. He has lectured worldwide on the Pathologies, Treatment and Prevention of muscular skeletal injuries.

His clinical interest is the assessment of pathoanatomical features of the Knee joint. He has developed a tertiary referral clinic for the investigation and management of knee pain with Professor John Fairclough highly qualified Consultant Orthopaedic Surgeons at the CMAT centre (Centre for Musculoskeletal Analysis and Therapy, Cardiff UK) where there is provision both diagnostic and therapeutic rehabilitation and is widely used by professional and amateur sports teams and individuals. He recently created jointly with Dr Eric Lespessailles (Rheumatologist and Professor associate at Orleans university) private referral clinic at the Regional Hospital at Orleans for the investigation and management of knee pain

2009 - present Assistant Professor in Department of Molecular Science and Technology, Ajou University, Korea 2002 - 2003 Post Doct., in Institute for Medicine and Engineering, University of Pennsylvania, USA 2001 - 2002 Post Doct., in Department of Chemistry, University of Massachusetts Lowell, USA 1998 - 2001 Ph.D., in Department of Electronic Chemistry, Tokyo Institute of Technology, Japan 1986 - 1990 B.S., in Department of Polymer Science and Engineering, Inha University, Korea 1996-1998 M.S., in Department of Polymer Science and Engineering, Inha University, Korea

Polymer Science and Engineering

Dr. Ramaiah Muthyala holds Ph.D (Natural Products), Ph.D. (Heterocyclic Chemistry) and MBA (International Management). He is Fellow of Royal Society of Chemistry. Among other awards, he received SC Amita award from the Indian Chemical Society. He has been editor or and coeditor of books, book chapters and has been in editorial boards of ARKIVOC, Mini-reviews in Medicinal Chemistry. For the last 12 years, Dr. Muthyala has been at the University of Minnesota where he was Associate Director, Center for Drug Design, and Associate Director (pre-clinical development) Center for Orphan Drug Research. He is also Associate Professor, Department of Experimental Clinical Pharmacology and Adjunct Professor, Department of Medicine. His research interests focused in rare diseases - the discovery and development of therapeutics for drug resistant bacterial infections, neurological diseases such as SCA1 and hemoglobinopathy such sickle cell disease. In his research, drug repositioning takes major emphasis to discovering drug leads.

The vision of our research program is to translate biological and chemical information into leads to drug-like molecules and optimize the lead small molecules to drug molecules using synthetic organic chemistry. The drug discovery will be combined with structure information obtained from ligand-protein structures, enzyme data derived from computational, modeling and biological experiments. The potential for speedy optimization of drug discovery, selective and carefully designed combinatorial small libraries along with rapid, sensitive and specific assay procedures are being explored. Natural products with desired biological activity at nanomolar range are considered as informed lead compounds for further development into drug candidates.

Filippo Boniforti has degeed at the age of 26 years from Universita’ degli Studi di Milano School of Medicine and specialized in orthopedics surgery. He is the director of the Orthopedic Department of the Fondazione San Raffaele Giglio di Cefalu (I). He has published more than twenty papers in reputed journals and serving as an editorial board member of repute orthopedic societies.

He leads orthopaedic hospital unit, 16 beds for orthoapedic treatments. He runs surgical theatre for more than 800 procedures per year. Hip and knee joint replacement (primary and revision) are the most significant filds of interest (>300 procs/year), pediatric orthopaedics and, proteogenomics.

Twenty years of experience studying of the role of the preotic anterior hypothalamic area in the central control of host defense mechanisms; LPS effects on neurotransmitters and hypothalamic releasing hormones, LPS-fever, and endotoxic hypotension, make me well suited to be the Principal Investigator in the project with Dr. Arnold Johnson as Co-Investigator. The proposal pertains to the elucidation of the role of preoptic hypothalamic endocannbinoids in the lung response to endotoxemia. After five years of postdoctoral research associate/instructor and research assistant professor positions at St. Jude Children’s Research Hospital and the University of Tennessee, Health Science Center, respectively, I accepted a tenure track Assistant Professor position at Albany College of Pharmacy and Health Sciences in the fall of 2005. I have been successful in transitioning from a purely Research environment to one that has more balance of teaching and research. I successfully taught large lecture pathophysiology and pharmacology courses, a small neuroimmunology elective course and a graduate topics course in inflammation and prostaglandins. At the same time, I have developed my lab to the point where it is producing publishable data and is attracting both undergraduate and graduate students. I obtained an R15 AREA grant in the field of LPS fever and fellowships for students in the lab. As a result, I was promoted to Associate professor with tenure. To date, I have mentored 18 undergraduate students (both B.S. and Pharm.D. students) in my lab. Recently, one of these students, Janey James, was accepted at Mount Sinai Hospital, New York, NY, Graduate program. Three of my undergraduate students have competed for and received ACPHS Student Summer Research Awards to pursue research with me during the summers. I am also actively participating in mentoring students in the MS Pharmaceutical Sciences program with one of my graduate students successfully defending her thesis last week and accepted into the prestigious PhD program in immunology at Rutgers University. The undergraduate and graduate students in my lab have been major contributors to my research program in the last 9 years as evidenced by the publication/presentations in national and international meetings, and manuscripts under preparation/submitted (11, 12, 13, 15). In addition to these publications and presentations, students from my lab are the first author/co-author on two other manuscripts that are currently under review.

Host defense mechanisms,LPS effects on neurotransmitters

Upon completion of his doctorate in chemistry at The University of Tokyo in 1995 Dr. Yan joined the R&D group at Ibaraki Research Laboratory, Hitachi Chemical Industry Co. Ltd. where he carried out research works to develop sophisticated electronic components by utilizing functional polymers. After his research works on conductive polymers at Tokyo University of Science, Yamaguchi for 6 years, and on polymer gels and super water-repellent materials at Hokkaido University for 3 years, Dr. Yan joined the Laboratory of Organic Robotics at the University of Yamanashi in 2007 where he is an Associate Professor. Before his above career in Japan, Dr. Yan had been educated in China, i.e., in Jilin University (1978-1982) for Bachelor of Science on polymer chemistry and in Henan Institute of Chemistry (1984-1987) for Master of Science on inorganic chemistry. Dr. Yan who is a full professor of Zhengzhou University since 2011, has published 8 books, 59 original papers, and 31patents. Currently, Dr. Yan is also an Editorial Board Member, Journal of Bioequivalence & Bioavailability(OMICS Publishing Group, USA), and an Editorial Advisory Board Member, Recent Patents on Materials Science (Bentham Science Publishers, Ltd., USA).

Polymer Chemistry

Dr. Adam Le Gresley obtained his PhD from the University of Surrey, working under Professor Nikolai Kuhnert on the synthesis of Calix[4]arene derivatives for dynamic combinatorial libraries. He undertook his postdoctoral work as an NIH Research Fellow at Drexel College of Medicine in the USA, working on the synthesis and evaluation of "caged" compounds for probing biological pathways. Since joining Kingston University in 2009, He have established a research group in organic and analytical chemistry, funded by industrial sponsors such as GlaxoSmithKline and LGC Ltd, working on the design and synthesis of fluorogenic compounds for problem pathogen detection and method development for NMR metabolomics/2D qNMR for complex mixture analysis and metrology. He have collaborations with institutions in Germany, Australia and the USA. He have 20 publications in peer-reviewed journals and 2 patents.

Metrology and G-quadruplex ligand development for cancer treatment

Pillhun son is broadly experienced in working with diverse teams internally and externally in global environments. Fearless in diving into new tasks and passionate in facing challenges and resolving obstacles. Powerful aptitude in problem solving and efficient in leading large teams in goal-oriented projects. Constant research and continuous learning of related topics, competition, and applicable successful models. Pill Hun Son earned his PhD from Texas Tech University in Organic and Computational Chemistry and then moved on to work on Material Science and Physical Chemistry during his Postdoc. He has worked on several database building and information solution initiatives for CAS, including, CASREACT (CAS’s premier reaction database) and the all new Formulations information solution (set to launch mid 2017). Most recently, Pill also achieved a MS in Information Systems from Northwestern University.

Material Science and Physical Chemsitry

I have diverse leadership experience as a health services professional with significant accomplishments in all aspects of pharmacovigilance, clinical development, medical affairs, regulatory affairs, primary health care, project management & international health programs. I have vast experience of working in diverse therapeutic areas including rare diseases, novel preventive & therapeutic vaccines, monoclonal antibodies, cardiovascular, oncology, neurology, nosocomial diseases, generic and OTC medicines. I am currently working as Disease Area Cluster Lead for Biosimilars & Drug Delivery Devices at Pfizer. Currently Pfizer has the largest biosimilars portfolio in the industry that includes projects on Inflammation, Oncology, Hematology, ophthalmology etc. My past experience includes working as Associate vice president PV and Therapeutic Area Head (Rare Diseases) for Sanofi Genzyme, working as Senior Director & Director for vaccines PV at Sanofi Pasteur, working as Medical Consultant for Apotex Inc Canada. Prior to joining industry I had worked as Joint Executive Director for Pakistan Institute of Medical Sciences (PIMS), Registrar of the Post graduate medical institute PIMS and as Deputy Director General, Ministry of Health Pakistan. I have also worked on various primary healthcare, public health, health planning & development programs as well World food, UNICEF, WHO & JICA assisted programs on drug safety, emergency preparedness, and primary healthcare.

Pharmacovigilance, Drug safety

Dr. Tirotta has been an active member of Miami Children’s Hospital medical staff since 1991, practicing with the Department of Anesthesiology; he has served as the Director of Cardiac Anesthesia since 2002. He has served as Chief of the Department of Anesthesia since July 2017. He also has a clinical appointment with the Department of Anesthesiology at The University of Miami School of Medicine Dr. Tirotta received his BA from Cornell University in 1982 and his MD from New York University School of Medicine in 1986. He also received an MBA degree from Columbia University in 1999. Dr. Tirotta completed his internship in Internal Medicine at SUNY at Stony Brook in 1987. He completed his residency training in anesthesiology at the University of Miami/Jackson Memorial Hospital in 1990; he sub-specialized in pediatric and cardiovascular anesthesia, including heart transplantation. In 1994, Dr. Tirotta created and produced the widely acclaimed pre-operative educational video titled, “A Hospital Trip with Dr. Bip”. This program, narrated by the endearing animated character Dr. Bip, explains to young children what to expect when they go to the hospital for surgery. It also includes coloring books and stickers. This program was exhibited at numerous national medical conventions and has sold thousands of copies all over the English-speaking world. Dr. Tirotta is a member of numerous professional societies and has served on a number of hospital committees, including the Heart Program Executive Committee. He previously served as the Co-Chair of the Miami Children’s Hospital Physician Hospital Organization. He is also responsible for giving numerous medical lectures nationally and internationally and is actively engaged in clinical research. He has been the Principal Investigator on a number of clinical drug/device trials, including on the ONQ Pain Buster, the muscle relaxant Zemuron, the procoagulant RiaSTAP, the Cardiotronic NICOM device and the ClearLine.

Cardiovascular anesthesia including heart transplantation.